PhoenixBio Co., Ltd.
(株)フェニックスバイオ
2026/08/21 Updated
Market Cap:
$8.7M (¥1.4B)
Stock Price:
$2.14 (¥340)
Exchange Rate: 1 USD = ¥158.98
Stock Price Chart
2026/08/21 Updated11.05
PER (Price Earnings Ratio)
vs Industry Avg: +1.5
0.95
PBR (Price to Book Ratio)
vs Industry Avg: -0.3
0.00%
Dividend Yield
vs Industry Avg: -2.95%
Price Trend
2026/08/21 UpdatedShort-term
5-Day MA
-0.70%
Near-term
25-Day MA
-1.90%
Mid-term
75-Day MA
-8.72%
Long-term
200-Day MA
-22.22%
Price & Trading Details
2026/08/21 UpdatedPRICE
Previous Close
¥348
Open
¥348
High
¥348
Low
¥340
Close
¥340
TRADING
Volume
2,700
Average Volume
7,447
Turnover
¥918,000
Min. Purchase
¥34,000
Shareholder Composition
Updated 2026/08/0159.7%
Insider Holdings
0.0%
Institutional
40.4%
Public Float
0
Institutional Holders
Insider Holdings
59.7%
Institutional
0.0%
Public Float
40.4%
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥2,124M | ¥1,715M | ¥1,541M | ¥1,566M |
| Gross Profit | ¥1,556M | ¥1,195M | ¥1,118M | ¥1,201M |
| Operating Income | ¥508M | ¥11M | -¥142M | ¥83M |
| Pretax Income | ¥514M | ¥63M | -¥428M | ¥136M |
| Net Income | ¥493M | ¥26M | -¥449M | ¥125M |
| EPS | ¥97.29 | ¥6.98 | -¥110.83 | - |
| Operating Margin | 23.94% | 0.65% | -9.22% | 5.29% |
| Balance Sheet | ||||
| Total Assets | ¥3,019M | ¥2,715M | ¥2,285M | ¥2,193M |
| Total Equity | ¥1,514M | ¥1,798M | ¥1,365M | ¥1,553M |
| Total Liabilities | ¥1,504M | ¥918M | ¥920M | ¥640M |
| Cash | ¥1,555M | ¥1,385M | ¥1,149M | ¥1,147M |
| Interest-bearing Debt | ¥1,130M | ¥724M | ¥565M | ¥487M |
| Equity Ratio | 50.17% | 66.20% | 59.75% | 70.81% |
| D/E Ratio | 0.75 | 0.40 | 0.41 | 0.31 |
| Cash Flow | ||||
| Operating CF | ¥277M | -¥79M | -¥73M | ¥69M |
| Investing CF | -¥156M | ¥115M | -¥28M | -¥14M |
| Financing CF | ¥87M | -¥245M | -¥128M | -¥88M |
| Free CF | ¥265M | -¥118M | -¥105M | ¥54M |
| Efficiency | ||||
| ROE | 32.57% | 1.47% | -32.88% | 8.07% |
| ROA | 16.34% | 0.97% | -19.64% | 5.71% |
Latest IR Information
Latest News (5 items)
Company Information
English Name
PhoenixBio Co., Ltd.
Japanese Name
(株)フェニックスバイオ
Stock Code
6190.T (JPX)
Sector / Industry
Healthcare / Biotechnology
Website
https://phoenixbio.co.jp
Employees
55
About
PhoenixBio Co., Ltd. provides contract testing services for medical product development in Japan, the United States, and internationally. The company offers PXB-mouse, a chimeric mouse with a humanized liver used in drug development experiments; and PXB-cells, human hepatocytes for in vitro studies and experiments, as well as HBV study services. Its products are used in gene therapeutics, MASH/MAFLD, viral hepatitis, DMPK/toxicity, and custom transplantations applications. The company was founded in 2002 and is headquartered in Higashihiroshima, Japan.
Data provided by Yahoo Finance
